Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 12 Cognitive Dysfunction 4 Radiation Injuries 3 Neoplasms 3 Multiple Myeloma 3 Glioma 3 Lymphoma, B-Cell 2 Lymphoma 2 Glioblastoma 2 Fatigue 2 Breast Neoplasms 2 Astrocytoma 2 Triple Negative Breast Neoplasms 1 Stroke 1 Sarcoma 1 Pituitary Neoplasms 1 Parkinson Disease 1 Osteosarcoma 1 Oligodendroglioma 1 Neurotoxicity Syndromes 1 Neurofibromatosis 1 1 Neoplasm Metastasis 1 Meningioma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell, Marginal Zone 1 Lung Neoplasms 1 Localized, Operable Non-small Cell Lung Cancer 1 Liver Neoplasms 1 Liver Diseases 1

Interventions

Cyclophosphamide 165 fludarabine phosphate 110 Peripheral Blood Stem Cell Transplantation 94 Mycophenolic Acid 88 Whole-Body Irradiation 81 Etoposide 81 Tacrolimus 73 Busulfan 68 Melphalan 67 Filgrastim 66 fludarabine 62 Radiotherapy 56 Doxorubicin 54 Cyclosporine 54 Rituximab 50 Brentuximab Vedotin 48 Antilymphocyte Serum 47 Granulocyte Colony-Stimulating Factor 42 Vinblastine 41 Methotrexate 38 Dacarbazine 37 Cytarabine 35 Gemcitabine 34 Nivolumab 30 Bleomycin 29 Carmustine 28 Vincristine 25 Prednisone 25 Sirolimus 24 Bendamustine Hydrochloride 23

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Hodgkin Disease × Neuropsychological Tests × Clear all

NCT06116929 2024-02-28

FunC-AHOD

Lille Catholic University

Phase NA Not yet recruiting

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡